1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:PVO for complex intracranial aneurysms: summary of obliteration rates, morbidity, and mortality
Obliteration Rate (%) Mortality (%) Permanent Major Deficit (%) Permanent Minor Deficit (%) Anterior circulation aneurysms 83.3 0.0 0.0 8.3 Posterior circulation aneurysms presenting with SAH 83.6 0.0 0.0 0.0 Posterior circulation aneurysms presenting with mass effect 57.1 28.6 28.6 0.0 PCA aneurysms discovered incidentally 67.7 0.0 0.0 0.0